Keros Therapeutics

(NASDAQ) KROS

Current Price$10.52

Market Cap$207.77M

Since IPO (2020)-48%

5 Year-79%

1 Year-25%

1 Month-10%

Keros Therapeutics Financials at a Glance

Market Cap

$207.77M

Revenue (TTM)

$33.18M

Net Income (TTM)

$85.14M

EPS (TTM)

$-3.01

P/E Ratio

-3.49

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$10.52

Volume

20,103

Open

$10.81

Price

$10.52

Volume

20,103

Open

$10.81

Previous Close

$10.52

Daily Range

$10.30 - $10.81

52-Week Range

$10.30 - $22.55

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$10.52

Volume

20,103

Open

$10.81

Previous Close

$10.52

Daily Range

$10.30 - $10.81

52-Week Range

$10.30 - $22.55

KROS News

vaccine injection doctor health check-up

Why Shares of Keros Therapeutics Jumped This Week

James HalleyApr 21, 2023

Why Shares of Keros Therapeutics Rose 10.2% This Week

James HalleyOct 14, 2022

These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?

David HaenApr 23, 2020

KROS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Keros Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Jasbir S. Seehra, PhD

Website

www.kerostx.com

Headquarters

Lexington, MA 02421, US

KROS Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-17%

Return on Capital

-37%

Return on Assets

-27%

Earnings Yield

-28.65%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$207.77M

Shares Outstanding

19.79M

Volume

20.10K

Avg. Volume

424.82K

Financials (TTM)

Gross Profit

$242.55M

Operating Income

$70.62M

EBITDA

$72.13M

Operating Cash Flow

$107.50M

Capital Expenditure

$1.55M

Free Cash Flow

$105.95M

Cash & ST Invst.

$287.42M

Total Debt

$16.88M

Keros Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$367.00K

-99.8%

Gross Profit

$36.00K

-100.0%

Gross Margin

-9.81%

N/A

Market Cap

$207.77M

N/A

Market Cap/Employee

$1.27M

N/A

Employees

163

N/A

Net Income

$23.71M

-116.0%

EBITDA

$25.47M

-116.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$265.19M

-62.2%

Accounts Receivable

$2.65M

-86.3%

Inventory

$0.00

N/A

Long Term Debt

$13.81M

-15.3%

Short Term Debt

$2.50M

+19.0%

Return on Assets

-27.26%

N/A

Return on Invested Capital

-36.85%

N/A

Free Cash Flow

$3.60M

-102.2%

Operating Cash Flow

$3.53M

-102.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NAGENiagen Bioscience Inc

NAGENiagen Bioscience Inc$3.65-3.95%

RGNXREGENXBIO Inc.

RGNXREGENXBIO Inc.$5.72-8.41%

VSTMVerastem, Inc.

VSTMVerastem, Inc.$4.32-8.28%

RIGLRigel Pharmaceuticals, Inc.

RIGLRigel Pharmaceuticals, Inc.$29.01-9.12%

CTMXCytomX Therapeutics, Inc.

CTMXCytomX Therapeutics, Inc.$3.61-4.50%

ABSIAbsci Corporation

ABSIAbsci Corporation$5.13-7.40%

VTYXVentyx Biosciences, Inc.

VTYXVentyx Biosciences, Inc.$14.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

ONDSOndas

ONDSOndas$10.62-0.05%

NOKNokia

NOKNokia$13.95-0.04%

FFord Motor Company

FFord Motor Company$13.40-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.06-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$75.34-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.98+0.05%

PIIIP3 Health Partners

PIIIP3 Health Partners$11.29+1.80%

Questions About KROS

What is the current price of Keros Therapeutics?

Keros Therapeutics is trading at $10.52 per share.

What is the 52-week range for Keros Therapeutics?

Over the past 52 weeks, Keros Therapeutics has traded between $10.30 and $22.55.

How much debt does Keros Therapeutics have?

As of the most recent reporting period, Keros Therapeutics reported total debt of $16.31M.

How much cash does Keros Therapeutics have on hand?

Keros Therapeutics reported $281.50M in cash and cash equivalents in its most recent financial results.

What is Keros Therapeutics’s dividend yield?

Keros Therapeutics does not currently have a dividend yield.

Keros Therapeutics

Keros Therapeutics Financials at a Glance

KROS News

Why Shares of Keros Therapeutics Jumped This Week

Why Shares of Keros Therapeutics Rose 10.2% This Week

These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?

KROS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Keros Therapeutics

KROS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Keros Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KROS

What is the current price of Keros Therapeutics?

What is the 52-week range for Keros Therapeutics?

How much debt does Keros Therapeutics have?

How much cash does Keros Therapeutics have on hand?

What is Keros Therapeutics’s dividend yield?

Premium Investing Services